Abattis Bioceuticals (CSE:ATT) President and CEO Mike Withrow spoke to Cannabis Investing News at the GreenRush Financial Conference about Abattis’ approach to the up-and-coming medical marijuana industry.
So far, the company has seen marked success with its marijuana-related financing activities. Abattis is based in Canada, but has also expanded to the United States on the safety and testing side of the drug through Phytalitics, and on the transaction side through an IPS transaction company.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.